As a very simple explanation, Moebius syndrome is a form of facial paralysis combined with outward, to the side, eye paralysis. Individuals with Moebius syndrome typically cannot make facial expressions, such as smiling, frowning, squinting, or blinking. Speech, eating, and lip movement may also be affected. People with Moebius syndrome also cannot move their eyes out to the side, as you would if you were looking over your shoulder without turning your head. The syndrome has a wide range of presentations and may occur on one or both sides of the face.
Moebius syndrome is a congenital (present at birth), non-progressive facial weakness with limited outward horizontal movement of one or both eyes. An additional criterion of having full vertical (up and down) eye movement, prior to any eye surgery, has also been suggested.
Congenital facial weakness and the inability to abduct (move the eye away from the nose) in one or both eyes, must be present for a diagnosis of Moebius syndrome. These two symptoms may be due to the underdevelopment or absence of the facial nerve (cranial nerve 7) and the abducens nerve (cranial nerve 6), respectively.
Facial weakness caused by Moebius syndrome may present on one (unilateral) or both (bilateral) sides of the face.
Moebius syndrome may affect other cranial nerves (typically the lower ones, such as nerves 9, 11, and 12) in addition to nerves 6 and 7. Learn more about the 12 cranial nerves.
Moebius syndrome may occur with other clinical symptoms, including:
In most cases of Moebius syndrome, cognitive development is typical. When intellectual disability is present, affected persons tend to have additional clinical features such as congenital heart disease, cleft palate, and other systemic (body-wide) involvement and symptoms.
Genetic research into Moebius syndrome has identified other genetic conditions with clinical features overlapping with that of Moebius syndrome. They are:
This list is not inclusive of all congenital facial weakness conditions; please refer to “A Framework For the Evaluation of Patients With Congenital Facial Weakness” by Dr. Bryn D. Webb, et al. for more detailed information on the types of congenital facial weakness disorders.
Support, events, and information from the Moebius Syndrome Foundation are open to individuals with any form of congenital facial weakness, regardless of genetic cause or official diagnosis.
What is the cause of Moebius syndrome?
The cause of Moebius syndrome is not well understood. Genetic research into the condition has not shown a clear genetic pattern.
There is no family history of Moebius syndrome and it occurs sporadically. There are some conditions with overlapping features to Moebius syndrome that may run in families, but in studies supported by the Moebius Syndrome Foundation, no individuals with classic Moebius syndrome have more than one affected family member in their families.
While some research completed in Europe, with lead authors from the Netherlands, has indicated that Moebius syndrome may occur with changes in genes PLXND1 and REV3L, researchers in the United States have been unable to identify additional patients with changes in these two genes.
Moebius syndrome-like conditions may occur from fetal exposure to drugs that cause the constriction of blood vessels. However, it is important to understand that these drugs cause a minority of cases of Moebius syndrome.
Some medical literature has theorized that reduced blood flow, or vascular interruption, may contribute or be the cause of Moebius syndrome.
Research into the cause of Moebius syndrome is ongoing.
How Is Moebius Syndrome Diagnosed?
Moebius syndrome is primarily a clinical diagnosis, meaning it is identified based on a medical professional’s evaluation of a patient’s symptoms and physical examination, rather than a single definitive laboratory test.
The core diagnostic criteria require the presence of both:
A neurologist, geneticist, or craniofacial specialist typically leads the evaluation. The diagnostic workup may include:
Neurological examination to assess cranial nerve function
MRI or CT brain imaging to evaluate brainstem structure and look for hypoplasia (underdevelopment) of relevant cranial nerve nuclei
Ophthalmological assessment to document eye movement range
Genetic testing to rule out overlapping conditions
Hearing evaluation, as some individuals have associated hearing loss
Feeding and swallowing assessment, particularly in infants
While there is no cure for Moebius syndrome, many effective treatments and therapies can significantly improve quality of life. Management is typically individualized and multidisciplinary, meaning a team of specialists works together to address each person’s specific needs.
When Is Moebius Syndrome Typically Identified?
In many cases, Moebius syndrome is recognized at birth or within the first weeks of life. Parents and newborn care providers may notice:
Difficulty feeding or latching (due to limited lip movement and facial muscle weakness)
In milder presentations, the diagnosis may come later in infancy or childhood, sometimes prompted by speech delays, eye alignment concerns (strabismus), or a referral from a pediatrician who notices asymmetric facial movement.
How is Moebius syndrome treated and managed?
Treatment approaches vary depending on which cranial nerves are affected and the severity of presentation. Common areas of intervention include:
Speech & Feeding Therapy: Many infants with Moebius syndrome have difficulty feeding due to reduced lip seal and facial muscle tone. Speech-language pathologists (SLPs) work with families from early infancy to support safe feeding, and later assist with speech articulation, which can be affected by limited lip and tongue movement.
Physical & Occupational Therapy: For individuals with low muscle tone (hypotonia), limb differences, or club foot, physical and occupational therapy support motor development, strength, coordination, and daily function.
Eye Care: Because many individuals with Moebius syndrome cannot fully close their eyes or blink normally, protecting eye health is critical. This may involve lubricating eye drops, moisture chamber glasses, patching for amblyopia (lazy eye), and surgical intervention for strabismus (crossed eyes).
Dental Care: Reduced oral muscle tone, smaller jaws, and mouth-breathing can affect dental development. Regular dental monitoring and early orthodontic evaluation are recommended.
Smile Surgery (Gracilis Muscle Transfer): Some individuals with Moebius syndrome choose to undergo a surgical procedure called a gracilis free muscle transfer, in which a small muscle from the inner thigh is transplanted to the face to enable a smile. This is an elective procedure, typically performed in childhood or adulthood, and results vary. It is not appropriate for everyone and is a deeply personal decision.
Hearing Supports: For individuals with associated hearing loss, audiological evaluation and hearing aids or other assistive devices may be recommended.
The estimated incidence of Moebius syndrome is roughly 2 to 20 cases per 1 million births. Moebius syndrome occurs equally in all populations. The condition occurs in all ethnicities. There is no gender bias; males and females are affected equally.
Moebius syndrome was originally described by German ophthalmologist Alfred Graefe in 1880, but it is named for German neurologist Paul Julius Moebius, who reported features of this condition in 1888.
Citations:
Genetic Research into Moebius Syndrome, presented by Elizabeth Engle, M.D., Ethilyn Jabs, M.D., Irini Manoli, M.D., Bryn Webb, M.D. 2022 Moebius Syndrome Foundation Conference, Atlanta, GA.
Miller, G. Neurological disorders. The mystery of the missing smile. Science 2007;316:826-7.
Picciolini O, Porro M, Cattaneo E, Castelletti S, Masera G, Mosca F, Bedeschi MF. Moebius syndrome: clinical features, diagnosis, management and early intervention. Ital J Pediatr. 2016 Jun 3;42(1):56. doi: 10.1186/s13052-016-0256-5. PMID: 27260152; PMCID: PMC4893276.
Webb BD, Manoli I, Engle EC, Jabs EW. A framework for the evaluation of patients with congenital facial weakness. Orphanet J Rare Dis. 2021 Apr 7;16(1):158. doi: 10.1186/s13023-021-01736-1. PMID: 33827624; PMCID: PMC8028830.
Webb BD, Shaaban S, Gaspar H, Cunha LF, Schubert CR, Hao K, Robson CD, Chan WM, Andrews C, MacKinnon S, Oystreck DT, Hunter DG, Iacovelli AJ, Ye X, Camminady A, Engle EC, Jabs EW. HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1-/- mice. Am J Hum Genet. 2012 Jul 13;91(1):171-9. doi: 10.1016/j.ajhg.2012.05.018. Epub 2012 Jul 5. PMID: 22770981; PMCID: PMC3397264.